{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:17:05Z","timestamp":1786979825581,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00228-021-03127-8","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T11:03:34Z","timestamp":1617102214000},"page":"1333-1339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Randomized, placebo-controlled trial of orally administered vitamin K1 for warfarin-associated coagulopathy in Chinese patients with mechanical heart valves"],"prefix":"10.1007","volume":"77","author":[{"given":"Heng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-lian","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-jun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7860-6510","authenticated-orcid":false,"given":"Li","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"3127_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(09)60780-7","volume":"374","author":"JC Sun","year":"2009","unstructured":"Sun JC, Davidson MJ, Lamy A, Eikelboom JW (2009) Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends. Lancet 374:565\u2013576","journal-title":"Lancet"},{"key":"3127_CR2","doi-asserted-by":"publisher","first-page":"204S","DOI":"10.1378\/chest.126.3_suppl.204S","volume":"126","author":"J Ansell","year":"2004","unstructured":"Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E (2004) The pharmacology and management of the vitamin K antagonists. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:204S\u2013233S","journal-title":"Chest"},{"key":"3127_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","volume":"89","author":"SC Cannegieter","year":"1994","unstructured":"Cannegieter SC, Rosendaal FR, Bri\u00ebt E (1994) Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89:635\u2013641","journal-title":"Circulation"},{"key":"3127_CR4","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1001\/archinternmed.2009.176","volume":"169","author":"M Torn","year":"2009","unstructured":"Torn M, Cannegieter SC, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR (2009) Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients. Arch Intern Med 169:1203\u20131209","journal-title":"Arch Intern Med"},{"key":"3127_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","volume":"348","author":"G Palareti","year":"1996","unstructured":"Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A et al (1996) Bleeding complications of Oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT): Italian study on complications of Oral anticoagulant therapy. Lancet 348:423\u2013428","journal-title":"Lancet"},{"key":"3127_CR6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.7326\/0003-4819-120-11-199406010-00001","volume":"120","author":"EM Hylek","year":"1994","unstructured":"Hylek EM, Singer DE (1994) Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 120:897\u2013902","journal-title":"Ann Intern Med"},{"key":"3127_CR7","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(00)03125-1","volume":"356","author":"MA Crowther","year":"2000","unstructured":"Crowther MA, Julian J, McCarty D, Douketis J, Kovacs M, Biagoni L et al (2000) Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomized controlled trial. Lancet 356:1551\u20131553","journal-title":"Lancet"},{"key":"3127_CR8","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1001\/archinte.160.11.1612","volume":"160","author":"EM Hylek","year":"2000","unstructured":"Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE (2000) Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med 160:1612\u20131617","journal-title":"Arch Intern Med"},{"issue":"2 Suppl","key":"3127_CR9","doi-asserted-by":"publisher","first-page":"e152S","DOI":"10.1378\/chest.11-2295","volume":"141","author":"A Holbrook","year":"2012","unstructured":"Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ et al (2012) Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e152S\u2013e184S","journal-title":"Chest"},{"key":"3127_CR10","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","volume":"63","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA et al (2014) 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. J Am Coll Cardiol 63:2438\u20132488","journal-title":"J Am Coll Cardiol"},{"key":"3127_CR11","first-page":"105","volume":"144","author":"H Zhang","year":"2020","unstructured":"Zhang H, Dong Y, Ao X, Zhu D, Dong L (2020) Optimal oral anticoagulant therapy in Chinese patients with mechanical heart valves. Eur J Pharm Sci 144:105\u2013202","journal-title":"Eur J Pharm Sci"},{"key":"3127_CR12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1001\/archinte.158.5.528","volume":"158","author":"TR Lousberg","year":"1998","unstructured":"Lousberg TR, Witt DM, Beall DG, Carter BL, Malone DC (1998) Evaluation of excessive anticoagulation in a group model health maintenance organization. Arch Intern Med 158:528\u2013534","journal-title":"Arch Intern Med"},{"key":"3127_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.7326\/0003-4819-110-11-943_1","volume":"110","author":"J De la Rubia","year":"1989","unstructured":"De la Rubia J, Grau E, Montserrat I, Zuazu I, Paya A (1989) Anaphylactic shock and vitamin K1. Ann Intern Med 110:943","journal-title":"Ann Intern Med"},{"key":"3127_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1046\/j.1365-2125.1996.03847.x","volume":"41","author":"JR Soedirman","year":"1996","unstructured":"Soedirman JR, De Bruijn EA, Maes RA, Hanck A, Gr\u00fcter J (1996) Pharmacokinetics and tolerance of intravenous and intramuscular phylloquinone (vitamin K1) mixed micelles formulation. Br J Clin Pharmacol 41:517\u2013523","journal-title":"Br J Clin Pharmacol"},{"key":"3127_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00001721-200101000-00002","volume":"12","author":"CG Fondevila","year":"2001","unstructured":"Fondevila CG, Grosso SH, Santarelli MT, Pinto MD (2001) Reversal of excessive oral anticoagulation with a low oral dose of vitamin K1 compared with acenocoumarine discontinuation. A prospective, randomized, open study. Blood Coagul Fibrinolysis 12:9\u201316","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3127_CR16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1592\/phco.20.15.1159.34585","volume":"20","author":"RJ Patel","year":"2000","unstructured":"Patel RJ, Witt DM, Saseen JJ, Tillman DJ, Wilkinson DS (2000) Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation. Pharmacotherapy 20:1159\u20131166","journal-title":"Pharmacotherapy"},{"key":"3127_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/0003-4819-150-5-200903030-00005","volume":"150","author":"MA Crowther","year":"2009","unstructured":"Crowther MA, Ageno W, Garcia D et al (2009) Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med 150:293\u2013300","journal-title":"Ann Intern Med"},{"key":"3127_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM199507063330103","volume":"333","author":"SC Cannegieter","year":"1995","unstructured":"Cannegieter SC, Rosendaal FR, Wintzen AR et al (1995) Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 333:11\u201317","journal-title":"N Engl J Med"},{"key":"3127_CR19","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/archinte.164.8.880","volume":"164","author":"J Rosand","year":"2004","unstructured":"Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM (2004) The effect of warfarin and intensity of anticoagulation on outcome of intra-cerebral hemorrhage. Arch Intern Med 164:880\u2013884","journal-title":"Arch Intern Med"},{"key":"3127_CR20","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1161\/01.STR.26.8.1471","volume":"26","author":"RG Hart","year":"1995","unstructured":"Hart RG, Boop BS, Anderson DC (1995) Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 26:1471\u20131477","journal-title":"Stroke"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03127-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T03:06:29Z","timestamp":1628219189000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03127-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["3127"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03127-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,30]]},"assertion":[{"value":"30 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of West China Hospital, Sichuan University approved the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}